Company intelligence / Profile preview
MaveriX Oncology
Palo Alto, California, United Statesmaverixoncology.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
MaveriX Oncology is developing conditionally activated small molecule drug conjugates (CA‑SMDCs) and next‑generation antibody‑drug conjugates designed to co‑target cancer cells and immunosuppressive cells in the tumor immune microenvironment using tumor‑associated hydroxylase activity for selective activation. Its lead CA‑SMDC programs remain in IND‑enabling/preclinical development, with planned first‑in‑human Phase 1a/1b studies in multiple solid tumors but no reported clinical results yet.[2][6][8][11]
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeSmall molecule-drug conjugatesAntibody-drug conjugate
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
PPF Group (equity investment in Series A financing and board representation)[2][4]Sotio (option to license and co-develop MVX-5005 and related compounds in Europe with up to $138M in milestones)[2][4]Translational Genomics Research Institute (TGen) and TD2 for preclinical and development support (implied development collaboration)[2][4]
Beyond the preview
Go deeper on MaveriX Oncology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MaveriX Oncology.